Ultram and Tenosynovitis - a phase IV clinical study of FDA data

Summary:

Tenosynovitis is reported as a side effect among people who take Ultram (tramadol hydrochloride), especially for people who are female, 50-59 old, have been taking the drug for 2 - 5 years also take Ambien, and have Breast cancer.

The phase IV clinical study analyzes which people have Tenosynovitis when taking Ultram. It is created by eHealthMe based on reports of 26,802 people who have side effects when taking Ultram from the FDA, and is updated regularly.

What is Ultram?

Ultram has active ingredients of tramadol hydrochloride. It is often used in pain. eHealthMe is studying from 28,425 Ultram users. Check the latest studies of Ultram.

What is Tenosynovitis?

Tenosynovitis (inflammation of the fluid-filled sheath (called the synovium) that surrounds a tendon) is found to be associated with 457 drugs and 490 conditions by eHealthMe. Check the latest studies of Tenosynovitis.

On Jul, 13, 2026

26,802 people reported to have side effects when taking Ultram.
Among them, 39 people (0.15%) have Tenosynovitis.

Among these 39 people:

How long have people been on Ultram when they have Tenosynovitis? *

What is the gender of people who have Tenosynovitis when taking Ultram? *

female: 82.05 %
male: 17.95 %

What is the age of people who have Tenosynovitis when taking Ultram? *

What are other drugs people take besides Ultram? *

Neurontin: 19 people, 48.72%
Ambien: 19 people, 48.72%
Arimidex: 18 people, 46.15%
Aredia: 18 people, 46.15%
Lomotil: 17 people, 43.59%
Celebrex: 15 people, 38.46%
Mitoxantrone Hydrochloride: 14 people, 35.90%
Ms Contin: 14 people, 35.90%
Methotrexate: 14 people, 35.90%
Benadryl: 14 people, 35.90%

What are other side effects people have besides Tenosynovitis? *

Carpal Tunnel Syndrome (nerve compression at wrist results numbness weakness, pain , swelling): 25 people, 64.10%
Swelling: 24 people, 61.54%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 23 people, 58.97%
Nausea And Vomiting: 22 people, 56.41%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 22 people, 56.41%
Joint Pain: 21 people, 53.85%
Nausea (feeling of having an urge to vomit): 21 people, 53.85%
Injury: 20 people, 51.28%
Oedema Peripheral (superficial swelling): 20 people, 51.28%
Gastric Ulcer (stomach ulcer): 20 people, 51.28%

What are the existing conditions these people have? *

Breast Cancer: 18 people, 46.15%
Hot Flush (sudden feelings of heat): 14 people, 35.90%
Discomfort: 14 people, 35.90%
Ovarian Cancer (cancer of ovary): 14 people, 35.90%
Breast Cancer Metastatic: 14 people, 35.90%
Neoplasm Malignant (cancer tumour): 14 people, 35.90%
Migraine (headache): 14 people, 35.90%
Granulocyte Count Decreased: 13 people, 33.33%
Osteoporosis (bones weak and more likely to break): 4 people, 10.26%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 3 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Ultram and have Tenosynovitis?

- Check whether Tenosynovitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ultram:

Ultram (28,425 reports)

Tenosynovitis treatments and more:

Tenosynovitis (4,673 reports)

Browse all side effects of Ultram:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Tenosynovitis:

Tenosynovitis (457 drugs)

Browse all the conditions that are associated with Tenosynovitis:

Tenosynovitis (490 conditions)

Related publications that referenced our studies

Mansour HM, "Tramadol and Disseminated Intravascular Coagulopathy: A Case Report", Medicine Science, 2015 Jan .
Mansour HM, "Tramadol and Disseminated Intravascular Coagulopathy: A Case Report", Medicine Science, 2015 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on tramadol hydrochloride (the active ingredients of Ultram) and Ultram (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.